/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Lifecore Biomedical Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$7.625 -0.0104(-1.04%) LFCR at 04 Dec 2025 04:36 PM Drug Manufacturers - Specialty & Generic
Lowest Today 7.57
Highest Today 7.85
Today’s Open 7.715
Prev. Close 7.72
52 Week High 8.85
52 Week Low 4.76
Day’s Range: Low 7.57 High 7.85
52-Week Range: Low 4.76 High 8.85
1 day return -
1 Week return -3.23
1 month return +12.61
3 month return -3.72
6 month return +11.7
1 year return +0.32
3 year return -3.59
5 year return -31.33
10 year return -

Institutional Holdings

Wynnefield Capital Inc 12.57

Legion Partners Asset Management, LLC 11.85

Greenhaven Road Investment Management, L.P. 9.88

325 Capital LLC 5.78

BlackRock Inc 5.01

Vanguard Group Inc 4.30

Geode Capital Management, LLC 2.07

Vanguard Total Stock Mkt Idx Inv 2.06

Morgan Stanley - Brokerage Accounts 1.98

iShares Russell 2000 ETF 1.73

State Street Corp 1.42

DCF Advisers, LLC 1.24

Vanguard Institutional Extnd Mkt Idx Tr 1.09

Amvescap Plc. 1.01

Invesco Dorsey Wright SmallCap Momt ETF 0.96

Fidelity Small Cap Index 0.73

22NW, LP 0.71

Northern Trust Corp 0.65

Quinn Opportunity Partners LLC 0.54

Fidelity Extended Market Index 0.53

iShares Russell 2000 Growth ETF 0.49

Tocqueville Asset Management L.P. 0.41

LPL Financial Corp 0.40

LANDSCAPE CAPITAL MANAGEMENT,LLC 0.36

Vanguard Russell 2000 ETF 0.35

Royal Bank of Canada 0.33

UBS Group AG 0.26

State St Russell Sm Cap® Indx SL Cl I 0.24

Delafield Concentrated Value 0.24

Charles Schwab Investment Management Inc 0.23

1290 VT GAMCO Small Company Value IB 0.21

Extended Equity Market Fund K 0.19

Fidelity Total Market Index 0.19

Schwab Small Cap Index 0.19

iShares Russell 2000 Value ETF 0.18

NT R2000 Index Fund - NL 0.18

iShares Micro-Cap ETF 0.17

Bridgeway Ultra-Small Company Market 0.15

NT R2000 Index Fund - DC - NL - 3 0.14

Fidelity Series Total Market Index 0.14

Market Status

Strong Buy: 2

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 289.24 M

PB Ratio 197.9884

PE Ratio 0.0

Enterprise Value 410.64 M

Total Assets 239.34 M

Volume 138670

Company Financials

Annual Revenue FY25:128867000 128.9M, FY24:128261000 128.3M, FY23:185786000 185.8M, FY22:185786000 185.8M, FY21:544161000 544.2M

Annual Profit FY25:40298000 40.3M, FY24:41850000 41.9M, FY23:50553000 50.6M, FY22:50370000 50.4M, FY21:81474000 81.5M

Annual Net worth FY25:-38717000 -38.7M, FY24:12013000 12.0M, FY23:-46084000 -46.1M, FY22:-97431000 -97.4M, FY21:-32665000 -32.7M

Quarterly Revenue Q3/2025:31109000 31.1M, Q2/2025:36444000 36.4M, Q1/2025:35154000 35.2M, Q4/2024:32564000 32.6M, Q3/2024:24705000 24.7M

Quarterly Profit Q3/2025:7791000 7.8M, Q2/2025:13982000 14.0M, Q1/2025:9845000 9.8M, Q4/2024:11084000 11.1M, Q3/2024:5387000 5.4M

Quarterly Net worth Q3/2025:-9991000 -10.0M, Q2/2025:-1147000 -1.1M, Q1/2025:-14769000 -14.8M, Q4/2024:-6571000 -6.6M, Q3/2024:-16230000 -16.2M

Fund house & investment objective

Company Information Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of hyaluronate acid (HA) in bulk form, as well as formulated and filled syringes, cartridges, and vials for injectable products used in treating a range of medical conditions and procedures. Its product development services include analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and production of materials for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Organisation Drug Manufacturers - Specialty & Generic

Employees 406

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. Paul Josephs

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow